Phosphoinositide phosphatase SHIP-1 regulates apoptosis induced by edelfosine, Fas ligation and DNA damage in mouse lymphoma cells

Biochemical Journal

Volumn 440, Issue 1, 2011, Pages 127-135

  Alderliesten, Maaike C ^a   Klarenbeek, Jeffrey B ^a   Van Der Luit, Arnold H ^a,c   Van Lummel, Menno ^a,d   Jones, David R ^b   Zerp, Shuraila ^a   Divecha, Nullin ^b   Verheij, Marcel ^a   Van Blitterswijk, Wim J ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c Oncodesign   (France)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alkyl lysophospholipid; Apoptosis resistance; DNA damage; Fas CD95; SH2 (Src homology 2) domain containing inositol phosphatase (SHIP)

Indexed keywords

EDELFOSINE; FAS ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITIDE; PROTEIN TYROSINE PHOSPHATASE SHP; SPHINGOMYELIN;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CROSS RESISTANCE; DNA DAMAGE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LIGATION; LIPID BLOOD LEVEL; LYMPHOMA CELL; MEDIATOR; MOLECULAR MIMICRY; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; DNA DAMAGE; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FAS LIGAND PROTEIN; LYMPHOMA; MICE; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHOLIPID ETHERS; PHOSPHORIC MONOESTER HYDROLASES; PROTO-ONCOGENE PROTEINS C-AKT; TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS);

EID: 80054944899     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20110125     Document Type: Article

References (35)

1. van Blitterswijk, W. J. and Verheij, M. (2008) Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects. Curr. Pharm. Des. 14, 2061-2074
2. Munder, P. G. and Westphal, O. (1990) Antitumoral and other biomedical activities of synthetic ether lysophospholipids. Chem. Immunol. 49, 206-235
3. Ruiter, G. A., Zerp, S. F., Bartelink, H., van Blitterswijk, W. J. and Verheij, M. (1999) Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis. Cancer Res. 59, 2457-2463 (Pubitemid 29242297)
4. Ruiter, G. A., Zerp, S. F., Bartelink, H., van Blitterswijk, W. J. and Verheij, M. (2003) Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway. Anti-Cancer Drugs 2, 167-173 (Pubitemid 36269756)
5. van Blitterswijk, W. J., Hilkmann, H. and Storme, G. A. (1987) Accumulation of an alkyl lysophospholipid in tumor cell membranes affects membrane fluidity and tumor cell invasion. Lipids 22, 820-823 (Pubitemid 18001383)
6. van der Luit, A. H., Budde, M., Ruurs, P., Verheij, M. and van Blitterswijk, W. J. (2002) Alkyl-lysophospholipid accumulates in lipid rafts and induces apoptosis via raft-dependent endocytosis and inhibition of phosphatidylcholine synthesis. J. Biol. Chem. 277, 39541-39547 (Pubitemid 35190932)
7. van der Luit, A. H., Vink, S. R., Klarenbeek, J. B., Perrissoud, D., Solary, E., Verheij, M. and van Blitterswijk, W. J. (2007) A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells. Mol. Cancer Ther. 6, 2337-2344
8. Mollinedo, F., Fernandez-Luna, J. L., Gajate, C., Martin-Martin, B., Benito, A., Martinez-Dalmau, R. and Modolell, M. (1997) Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-XL. Cancer Res. 57, 1320-1328 (Pubitemid 27152558)
9. Ruiter, G. A., Verheij, M., Zerp, S. F. and van Blitterswijk, W. J. (2001) Alkyllysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis. Int. J. Radiat. Oncol. Biol. Phys. 49, 415-419 (Pubitemid 32120238)
10. Vink, S. R., Lagerwerf, S., Mesman, E., Schellens, J. H., Begg, A. C., van Blitterswijk, W. J. and Verheij, M. (2006) Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts. Clin. Cancer Res. 12, 1615-1622
11. Vink, S. R., van Blitterswijk, W. J., Schellens, J.H.M. and Verheij, M. (2007) Rationale and clinical application of alkylphospholipid analogues in combination with radiotherapy. Cancer Treat. Rev. 33, 191-202 (Pubitemid 46323398)
12. van Blitterswijk, W. J., Klarenbeek, J. B., van der Luit, A. H., Alderliesten, M. C., van Lummel, M. and Verheij, M. (2010) Fas/CD95 down-regulation in lymphoma cells through acquired alkyl-lysophospholipid resistance: partial role of sphingomyelin deficiency. Biochem. J. 425, 225-234
13. van der Luit, A. H., Budde, M., Zerp, S., Caan, W., Klarenbeek, J. B., Verheij, M. and van Blitterswijk, W. J. (2007) Resistance to alkyl-lysophospholipid-induced apoptosis due to downregulated sphingomyelin synthase 1 expression with consequent sphingomyelin and cholesterol deficiency in lipid rafts. Biochem. J. 401, 541-549 (Pubitemid 46166435)
14. Rohrschneider, L. R., Fuller, J. F., Wolf, I., Liu, Y. and Lucas, D. M. (2000) Structure, function, and biology of SHIP proteins. Genes Dev. 14, 505-520 (Pubitemid 30159771)
15. Harris, S. J., Parry, R. V., Westwick, J. and Ward, S. G. (2008) Phosphoinositide lipid phosphatases: natural regulators of phosphoinositide 3-kinases signalling in T lymphocytes. J. Biol. Chem. 283, 2465-2469
16. Ooms, L. M., Horan, K. A., Rahman, P., Seaton, G., Gurung, R., Kethesparan, D. S. and Mitchell, C. A. (2009) The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease. Biochem. J. 419, 29-49
17. Smets, L. A., van Rooij, H. and Salomons, G. S. (1999) Signaling steps in apoptosis by ether lipids. Apoptosis 4, 419-427
18. Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F. and Riccardi, C. (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139, 271-279
19. Serunian, L. A., Auger, K. R. and Cantley, L. C. (1991) Identification and quantification of polyphosphoinositides produced in response to platelet-derived growth factor stimulation. Methods Enzymol. 198, 78-87
20. Jones, D. R., González-García, A., Díez, E., Martinez-A, C., Carrera, A. C. and Meŕida, I. (1999) The identification of phosphatidylinositol 3,5-bisphosphate in T-lymphocytes and its regulation by interleukin-2. J. Biol. Chem. 274, 18407-18413
21. Duronio, V. (2008) The life of a cell: apoptosis regulated by the PI3K/PKB pathway. Biochem. J. 415, 333-344
22. Hayashi, H., Matsuzaki, O., Muramatsu, S., Tsuchiya, Y., Harada, T., Suzuki, Y., Sugano, S., Matsuda, A. and Nishida, E. (2006) Centaurin-α1 is a phosphatidylinositol 3-kinase-dependent activator of ERK1/2 mitogen-activated protein kinases. J. Biol. Chem. 281, 1332-1337
23. van der Luit, A. H., Budde, M., Verheij, M. and van Blitterswijk, W. J. (2003) Different modes of internalization of apoptotic alkyl-lysophospholipid and cell-rescuing lysophosphatidylcholine. Biochem. J. 374, 747-53 (Pubitemid 37163920)
24. Algeciras-Schimnich, A., Shen, L., Barnhart, B. C., Murmann, A. E., Burkhardt, J. K. and Peter, M. E. (2002) Molecular ordering of the initial signaling events of CD95. Mol. Cell Biol. 22, 207-220 (Pubitemid 33144269)
25. Gratacap, M.-P., Séverin, S., Chicanne, G., Plantavid, M. and Payrastre, B. (2008) Different roles of SHIP1 according to the cell context: the example of blood platelets. Adv. Enzyme Regul. 48, 240-252
26. Hamilton, M. J., Ho, V. W., Kuroda, E., Ruschmann, J., Antignano, F., Lam, V. and Krystal, G. (2011) Role of SHIP in cancer. Exp. Hematol. 39, 2-13
27. Horn, S., Endl, E., Fehse, B., Weck, M. M., Mayr, G. W. and Jucker, M. (2004) Restoration of SHIP activity in human leukemia cell line down-regulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3β signalling and leads to an increased transit time through the G1 phase of the cell cycle. Leukemia 18, 1839-1849 (Pubitemid 39530015)
28. Lioubin, M. N., Algate, P. A., Tsai, S., Carlberg, K., Aebersold, A. and Rohrschneider, L. R. (1996) p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev. 10, 1084-1095
29. Nishio, M., Watanabe, K., Sasaki, J., Tayca, C., Takasuga, S., Iizuka, R., Balla, T., Yamazaki, M., Watanabe, H., Itoh, R. et al. (2007) Control of cell polarity and motility by the PtdIns(3,4,5)P 3 phosphatase SHIP1. Nat. Cell Biol. 9, 36-44 (Pubitemid 46024195)
30. Brooks, R., Fuhler, G. M., Iyer, S., Smith, M. J., Park, M. Y., Paraiso, K. H., Engelman, R. W. and Kerr, W. G. (2010) SHIP1 inhibition increases immunoregulatory capacity and triggers apoptosis of hematopoietic cancer cells. J. Immunol. 184, 3582-3589
31. Lemmon, M. A. and Ferguson, K. M. (2000) Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochem. J. 350, 1-18
32. Freeley, M., Park, J., Yang, K. J., Wange, R. L., Volkov, Y., Kelleher, D. and Long, A. (2007) Loss of PTEN expression does not contribute to PDK-1 activity and PKC activation-loop phosphorylation in Jurkat leukaemic T cells. Cell. Signalling 19, 2444-2457 (Pubitemid 47542296)
33. Charlier, E., Condé, C., Zhang, J., Deneubourg, L., Di Valentin, E., Rahmouni, S., Chariot, A., Agostinis, P., Pang, P. C., Haslam, S. M. et al. (2010) SHIP-1 inhibits CD95/APO-1/Fas-induced apoptosis in primary T lymphocytes and T leukemic cells by promoting CD95 glycosylation independently of its phosphatase activity. Leukemia 24, 821-832
34. Liu, L., Damen, J. E., Hughes, M. R., Babic, I., Jirik, F. R. and Krystal, G. (1997) The Src homology 2 (SH2) domain of SH2-containing inositol phosphatase (SHIP) is essential for tyrosine phosphorylation of SHIP, its association with Shc, and its induction of apoptosis. J. Biol. Chem. 272, 8983-8988 (Pubitemid 27154897)
35. Gloire, G., Charlier, E., Rahmouni, S., Volanti, C., Chariot, A., Erneux, C. and Piette, J. (2006) Restoration of SHIP-1 activity in human leukemic cells modifies NF-κB activation pathway and cellular survival upon oxidative stress. Oncogene 25, 5485-5494 (Pubitemid 44344099)